# A Study of Two Different Formulations of LY3074828 in Healthy Participants

> **NCT03188510** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 54 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** LY3074828

## Key facts

- **NCT ID:** NCT03188510
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-30
- **Primary completion:** 2017-11-27
- **Final completion:** 2017-11-27
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2024-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03188510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03188510, "A Study of Two Different Formulations of LY3074828 in Healthy Participants". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03188510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*